This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pratt, S. E. Articles by Pollak, M. N. Search for Related Content PubMed PubMed Citation Articles by Pratt, S. E. Articles by Pollak, M. N.

Estrogen and Antiestrogen Modulation of MCF7 Human Breast Cancer Cell Proliferation Is Associated with Specific Alterations in Accumulation of Insulin-like Growth Factor-binding Proteins in Conditioned Media¹

Departments of Medicine and Oncology, McGill University, Montreal, Quebec, Canada H3T 1E2

Many neoplastic cell lines secrete insulin-like growth factor binding proteins (IGFBPs). The physiological role of these proteins is incompletely characterized; under various conditions IGFBPs have been observed to either enhance or inhibit the biological activity of insulin-like growth factors. MCF7 human breast cancer cells are known to be mitogenically responsive to insulin-like growth factors and estrogens, to secrete several IGFBPs, including BP-2, BP-4 and BP-5, and to be growth inhibited by antiestrogens. We report here that the pure antiestrogen ICI 182,780 and, to a lesser extent, the commonly used drug tamoxifen significantly increase levels of a M_r 43,000–46,000 IGFBP (BP-3) and significantly reduce levels of a M_r 24,000 IGFBP (BP-4) in the conditioned medium of MCF7 cells. Effects of estradiol and antiestrogens on M_r 30,000 and M_r 36,000 IGFBPs are also described. The effects of ICI 182,780 on IGFBPs in the conditioned medium of MCF7 cells may contribute to the remarkable ability of this compound to attenuate insulin-like growth factor I stimulated MCF7 cell proliferation.

¹ This work was supported by a grant to M. N. P. from the National Cancer Institute of Canada.

² To whom requests for reprints should be addressed, at McGill University and Lady Davis Research Institute of the Jewish General Hospital, 3755 Cote St. Catherine, Montreal, PQ, Canada H3T 1E2.

Received 4/ 5/93. Accepted 8/24/93.

This article has been cited by other articles:

				K. MCCARTHY, C. LABAN, C.J MCVITTIE, W. OGUNKOLADE, S. KHALAF, S. BUSTIN, R. CARPENTER, and P.J. JENKINS The Expression and Function of IGFBP-3 in Normal and Malignant Breast Tissue Anticancer Res, October 1, 2009; 29(10): 3785 - 3790. [Abstract] [Full Text] [PDF]

				P. M. Yamada and K.-W. Lee Perspectives in mammalian IGFBP-3 biology: local vs. systemic action Am J Physiol Cell Physiol, May 1, 2009; 296(5): C954 - C976. [Abstract] [Full Text] [PDF]

				G. Walker, K. MacLeod, A. R.W. Williams, D. A. Cameron, J. F. Smyth, and S. P. Langdon Insulin-like Growth Factor Binding Proteins IGFBP3, IGFBP4, and IGFBP5 Predict Endocrine Responsiveness in Patients with Ovarian Cancer Clin. Cancer Res., March 1, 2007; 13(5): 1438 - 1444. [Abstract] [Full Text] [PDF]

				J. Yang, Z. Chen, Y. Liu, R. J. Hickey, and L. H. Malkas Altered DNA Polymerase {iota} Expression in Breast Cancer Cells Leads to a Reduction in DNA Replication Fidelity and a Higher Rate of Mutagenesis Cancer Res., August 15, 2004; 64(16): 5597 - 5607. [Abstract] [Full Text] [PDF]

				L. Peng, P. J. Malloy, and D. Feldman Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter Mol. Endocrinol., May 1, 2004; 18(5): 1109 - 1119. [Abstract] [Full Text] [PDF]

				E. M. Ongeri, Q. Zhu, M. F. Verderame, and J. M. Hammond Insulin-Like Growth Factor-Binding Protein-3 in Porcine Ovarian Granulosa Cells: Gene Cloning, Promoter Mapping, and Follicle-Stimulating Hormone Regulation Endocrinology, April 1, 2004; 145(4): 1776 - 1785. [Abstract] [Full Text] [PDF]

				J. Eng-Wong, S. D. Hursting, D. Venzon, S. N. Perkins, and J. A. Zujewski Effect of Raloxifene on Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Leptin in Premenopausal Women at High Risk for Developing Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1468 - 1473. [Abstract] [Full Text] [PDF]

				G. E. Walker, E. M. Wilson, D. Powell, and Y. Oh Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex Endocrinology, September 1, 2001; 142(9): 3817 - 3827. [Abstract] [Full Text] [PDF]

				H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF]

				H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text]

				J. A. Thompson, P-L. Chen, R. A. King, S. S. Rich, W. S. Oetting, C. Armstrong, A. R. Folsom, and T. A. Sellers BRCA1 Susceptibility Markers and Postmenopausal Breast Cancer: The Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 507 - 511. [Abstract] [Full Text]

				S. Ménard, P. Aiello, E. Tagliabue, C. Rumio, P. L. Lollini, M. I. Colnaghi, and A. Balsari Tamoxifen Chemoprevention of a Hormone-independent Tumor in the Proto-neu Transgenic Mice Model Cancer Res., January 1, 2000; 60(2): 273 - 275. [Abstract] [Full Text]

				W.-M. Liu, F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu HMG-I(Y) Recognizes Base-unpairing Regions of Matrix Attachment Sequences and Its Increased Expression Is Directly Linked to Metastatic Breast Cancer Phenotype Cancer Res., November 1, 1999; 59(22): 5695 - 5703. [Abstract] [Full Text] [PDF]

				C. Qin, P. Singh, and S. Safe Transcriptional Activation of Insulin-Like Growth Factor-Binding Protein-4 by 17{beta}-Estradiol in MCF-7 Cells: Role of Estrogen Receptor-Sp1 Complexes Endocrinology, June 1, 1999; 140(6): 2501 - 2508. [Abstract] [Full Text]

				Y. Oh, H. L. Müller, L. Ng, and R. G. Rosenfeld Transforming Growth Factor- [IMAGE]-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action J. Biol. Chem., June 9, 1995; 270(23): 13589 - 13592. [Abstract] [Full Text] [PDF]

				S. Fanayan, S. M. Firth, A. J. Butt, and R. C. Baxter Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-beta (TGF-beta ) and the Type II TGF-beta Receptor J. Biol. Chem., December 8, 2000; 275(50): 39146 - 39151. [Abstract] [Full Text] [PDF]